AU Patent

AU2015288644B2 — Aqueous ophthalmic composition

Assigned to Fujifilm Corp · Expires 2017-12-14 · 8y expired

What this patent protects

An aqueous ophthalmic composition containing a carbonic anhydrase inhibitor, one or more cellulose derivatives selected from hydroxypropylmethylcellulose acetate succinate and carboxymethylethylcellulose, and water.

USPTO Abstract

An aqueous ophthalmic composition containing a carbonic anhydrase inhibitor, one or more cellulose derivatives selected from hydroxypropylmethylcellulose acetate succinate and carboxymethylethylcellulose, and water.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015288644B2
Jurisdiction
AU
Classification
—
Expires
2017-12-14
Drug substance claim
No
Drug product claim
No
Assignee
Fujifilm Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.